Phenylephrine HCl injection recalled for lack of sterility assurance
Nephron Sterile Compounding Center recalls Phenylephrine HCl Injection syringes nationwide due to lack of sterility assurance. Patients with affected lots should contact their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for injectable medication with potential sterility compromise. No illnesses or injuries reported in source; the hazard represents risk of harm without documented adverse events, meeting the rubric criterion for score 3 (High).
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Phenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL) pre-filled syringes. The affected product includes 18,930 syringes packaged as 5 x 10 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Cartons per case.
The recall is issued due to lack of assurance of sterility. Phenylephrine is an injectable medication used to manage blood pressure, and products without assured sterility pose a potential risk of serious infection.
The recalled product was distributed nationwide in the United States. The affected lot is PE2018A with an expiration date of 10/3/2022. The product is identified by FDA NDC 69374-956-10.
Patients who have received this product should contact their healthcare provider or pharmacist. Do not use the recalled syringes. For questions, contact Nephron Sterile Compounding Center LLC at 4500 12th St. Extension, West Columbia, SC 29172.
The recalled product
- Product
- Phenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL)syringe, packaged in 5 x 10 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-956-10
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Injectable / Parenteral
- Hazard
- sterility-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: PE2018A
- Exp. 10/3/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27